Cavan redmond biography samples

ALAMEDA, Calif., April 02, 2018 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE American:OCX) today announced that Cavan Redmond, a director of the Company since 2015, has been named Chairman of the Board of Directors.

Cavan Redmond, 54, joined our Board of Directors in August of Since , Mr. Redmond has served as Partner for Zarsy, LLC. Mr. Redmond served as.

Cavan Redmond, 54, joined our Board of Directors in August of Since , Mr. Redmond has served as Partner for Zarsy, LLC. Mr. Redmond served as.

Cavan.

Mr.

The sample included adults with arthritis who are engaged with the Arthritis Foundation.

The project completed all its sampling, both passive and fish tissue, in the Clark Fork River.

Alfred D. Kingsley, who has been Chairman since 2009 and was instrumental in forming OncoCyte and in taking it public in 2015, will remain a director.

Mr. Redmond’s career brings a unique combination of R&D and commercial experience in biotechnology and consumer healthcare.

He has held global leadership roles in a number of prominent life sciences companies, previously serving as CEO of WebMD Health Corp., where he streamlined operations to position the company for growth. While at Pfizer he was the head of Corporate Strategy; he also served as Senior Vice President at Pfizer, Inc.

and Group President, Pfizer Diversified Businesses. The Diversified Business included Animal Health, Consumer Healt